Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion

Journal: Cancer Cell

Published: 2020-05-13

DOI: 10.1016/j.ccell.2020.04.017

Affiliations: 18

Authors: 39

Go to article
Institutions Share
Department of Systems Biology, City of Hope, United States of America (USA) 0.42
Beckman Research Institute, City of Hope, United States of America (USA) 0.10
Department of Molecular Medicine, City of Hope, United States of America (USA) 0.08
Department of Medical Oncology and Therapeutics Research, City of Hope, United States of America (USA) 0.05
UC Division of Experimental Hematology and Cancer Biology, United States of America (USA) 0.05
Gehr Family Center for Leukemia Research, City of Hope, United States of America (USA) 0.04
Comprehensive Cancer Center, City of Hope, United States of America (USA) 0.04
Department of Pathology and Genomic Medicine, Houston Methodist, United States of America (USA) 0.04
Changsha Medical University, China 0.04
State Key Laboratory of Drug Research (SKLDR), SIMM CAS, China 0.03
College of Pharmacy-Glendale, MWU, United States of America (USA) 0.03
Cancer Center, MGH, United States of America (USA) 0.03
Department of Radiology at Sun Yat-sen Memorial Hospital, SYSU, China 0.01
Department of Hematology at First Affiliated Hospital, ZJU, China 0.01
Department of Liver Surgery at Renji Hospital, SJTU, China 0.01
Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), China 0.01
Key Laboratory for Modern Drug Delivery and High-Efficiency, TJU, China 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER